If the supporter lesions of the intestinal cancer can be detected at early stages, they are easily treated by removing them under endoscopy. Therefore, development of effective scanning strategies for early diagnosis in intestinal cancers is vital.
Although colonoscopy is the best method in detecting intestinal cancers, its application in scanning programs is not suitable due to inconveniency and difficulty of the application to patients. Therefore, there is a need for suitable biochemical tumor determinant markers that may be applied in scanning of patients under a cancer risk.
The tumor M2-PK (M2-pyruvate kinase), a recently developed new biochemical determinant markers , is very effective in detecting intestinal cancers at an early stage.
Pyruvate kinase (PK) is an enzyme applied in energy production from sugar. A special type of this enzyme M2-PK plays a role in the course of development of cancer.